|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MASCC Guidelines| > Search by Study Group |
|
Antiemetics |
Antiemetics Study Group
| DOWNLOAD GUIDELINES - click here • MASCC resources are available for download by providing a valid email address. |
|
MASCC MEMBERS - CLICK HERE NON-MEMBER ACCESS: (*indicates required fields ) |
Bone and Musculoskeletal Study Group
| DOWNLOAD GUIDELINES - click here • MASCC resources are available for download by providing a valid email address. |
|
MASCC MEMBERS - CLICK HERE NON-MEMBER ACCESS: (*indicates required fields ) |
| Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Yarom N et al. J Clin Oncol. 2019 Jul 22 |
|
 Guideline Summary Slide Set (2019) |
Guideline Summary (2019) |
Immuno-Oncology (Neutropenia Subgroup)
Mucositis Study Group
| DOWNLOAD GUIDELINES - click here • MASCC resources are available for download by providing a valid email address. |
|
MASCC MEMBERS - CLICK HERE NON-MEMBER ACCESS: (*indicates required fields ) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Summary - Original article MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy Elad S et al. Cancer. 2020 Jul 28 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Guideline Summary Translations - Available in Arabic, French, German, Greek, Japanese, Portuguese (Brazil and Portugal dialects) and Spanish. |
|
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Introduction to part 1 The MASCC/ISOO Mucositis Guidelines 2019 Update: introduction to the first set of articles Elad S. Support Care Cancer. 2019 Jul 8 |
|
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Introduction to part 2 The MASCC/ISOO Mucositis Guidelines 2019: the second set of articles and future directions Elad S. Support Care Cancer. 2020 Feb 12 |
|
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Methods Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods Ranna V et al. Support Care Cancer. 2019 Jul 8 |
|
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Basic oral care Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines Hong CHL et al. Support Care Cancer. 2019 Jul 8 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Photobiomodulation therapy / laser Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines Zadik Y et al. Support Care Cancer. 2019 Jul 8 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Anti-inflammatory agents Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines Ariyawardana A et al. Support Care Cancer. 2019 Jul 8 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Natural and miscellaneous agents – Part 1 Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements Yarom N et al. Support Care Cancer. 2019 Jul 8 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Natural and miscellaneous agents – Part 2 Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents Yarom N et al. Support Care Cancer. 2020 Feb 13 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Antimicrobials, mucosal coating agents, anesthetics, and analgesics Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines Saunders DP et al. Support Care Cancer. 2020 Feb 12 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – Cryotherapy Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines Correa MEP et al. Support Care Cancer. 2019 Dec 14 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guideliness – Growth factors and cytokines Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines Logan RM et al. Support Care Cancer. 2020 Feb 21 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – all interventions for GI mucositis Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines Bowen JM et al. Support Care Cancer. 2019 Jul 8 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – sub-analysis: all interventions in pediatric patients MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients Miranda-Silva W et al. Support Care Cancer. 2020 Nov 6 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – systematic review – pathogenesis The pathogenesis of mucositis: updated perspectives and emerging targets Bowen J et al. Support Care Cancer. 2019 Jul 8 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
| Mucositis Study Group, MASCC/ISOO mucositis guidelines – systematic review – risk prediction Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action Wardill HR et al. Support Care Cancer. 2020 Jun 26 |
|
| Guideline Summary Slide Set (2019 - 2020 version) |
Guideline Summary (2019 - 2020 version) |
Oncodermatology Study Group
| DOWNLOAD GUIDELINES - click here • MASCC resources are available for download by providing a valid email address. |
|
MASCC MEMBERS - CLICK HERE NON-MEMBER ACCESS: (*indicates required fields ) |
| Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group - UNDER REVISION Wong RKS et al. Support Care Cancer. 2013 Aug 14 |
|
| Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities Lacouture ME et al. Support Care Cancer. 2011 Jun 1 |
|
| Guideline Summary Slide Set (2011) |
|
Oral Care Study Group
| DOWNLOAD GUIDELINES - click here • MASCC resources are available for download by providing a valid email address. |
|
MASCC MEMBERS - CLICK HERE NON-MEMBER ACCESS: (*indicates required fields ) |
| Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies (ISOO/MASCC/ASCO Guideline) Mercadante V et al. Support Care Cancer. 2021 Sep 1 |
|
| Guideline Summary Slide Set (2021) |
Guideline Summary (2021) |
Palliative Care Study Group
| DOWNLOAD GUIDELINES - click here • MASCC resources are available for download by providing a valid email address. |
|
MASCC MEMBERS - CLICK HERE NON-MEMBER ACCESS: (*indicates required fields ) |
| Antiemetics in advanced cancer (MASCC updated guideline) - UPDATED Davis M et al. Support Care Cancer. 2021 Aug 16 |
|
| Guideline Summary Slide Set (2021) |
Guideline Summary (2021) |
| Nausea and vomiting in malignant bowel obstruction - UPDATED Davis M et al. Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update. Support Care Cancer. 2021 Aug 14 |
|
| Guideline Summary Slide Set (2021) |
Guideline Summary (2021) |
| The use of clinically assisted nutrition in patients with advanced cancer (MASCC expert opinion/guidance) - NEW Alderman B et al. Support Care Cancer. 2021 Oct 19 |
|
| Guideline Summary Slide Set (2021) |
Guideline Summary (2021) |
| Management of malignant bowel obstruction in advanced cancer (MASCC multidisciplinary evidence-based recommendations) - NEW Madariaga A et al. Support Care Cancer. 2022 Mar 10 |
|
Privacy Notice | Donate | Membership | Contact MASCC | Help
© Copyright 2020. Multinational Association of Supportive Care in Cancer (MASCC). All Rights Reserved Worldwide.
MASCC is a tax-exempt 501(c)3 corporation.
